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Inﬂammatory cytokinesBiodegradablemicro/nanoparticles generated from PLGA have recently attracted attention due to their clinically
proven biocompatibility, especially for immunization purposes. These polymeric particulate delivery systems are
able to present antigens and activate both humoral and cellular responses. Many studies have discussed the ideal
size of these particles in contributing to the generationof the different types of immune response.However, these
studies do not demonstrate the effect of micro or nanoparticles, without any encapsulated bioactive, on
phagocytic cells after the uptake process. In this context, the aim of this study was to analyze the in vitro
inﬂammatory behavior of J774murine macrophages after particles' uptake, since nano/microparticles per se can
differently activate phagocytic cells, using or not appropriate receptors, inducing distinct inﬂammatory
responses. An o/w emulsion solvent extraction–evaporation method was chosen to prepare the particles. We
determined their diameters, zeta potential and morphology. Fluorescent particles' uptake by J774 murine
“macrophage-like” cells was also analyzed. To evaluate the in vitro inﬂammatory proﬁle of these cells after micro
or nanoparticles' uptake, we conducted NF-κB translocation assay by confocal microscopy and also determined
the pro-inﬂammatory cytokines production provoked by the particles.duação, Pesquisa e Extensão,
ué Montello, 1, 65075-120, São
55 98 3235 8600.
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Particles made from poly (lactic-co-glycolic acid) (PLGA) can be
used as a delivery system and also provide adjuvant activity [1,2]
during immunization protocols. Biodegradable micro/nanoparticles
generated from PLGA have recently attracted attention due to their
clinically proven biocompatibility [3]. In addition to facilitating the
uptake of encapsulated materials, PLGA particles also potentially
protect different molecules, such as nucleic acids, peptides and
protein antigens, increasing delivery efﬁciency [4]. These polymeric
particulate delivery systems are able to present antigens and activate
both humoral and cellular responses [2,5,6]. Many studies have
discussed the ideal size of these particles in contributing to the
generation of immune response [7–9]. Polymer-entrapped antigens
reveal that micron-sized range particles promote humoral response
whereas nanoparticles promote cellular one [10,11]. In this context, it
is difﬁcult to predict the behavior of phagocytes after particles' uptake,
since nano/microparticles per se can differently activate phagocytic
cells, using or not appropriate receptors, inducing distinct inﬂamma-tory responses. The presence of the biomaterial component inside the
cell may increase the immune response against the biological
component through an adjuvant effect, and also lead to unexpected
inﬂammatory proﬁle.
The link between the activation of NF-κB and inﬂammation has
been shown in various human and animal models of disease. In most
cases, resident cells or those from infected tissue initiate the
inﬂammatory response by triggering pro-inﬂammatory pathways
through NF-κB in response to inﬂammatory stimuli [12]. In canonical
NF-κB signaling pathways, the pro-inﬂammatory cytokine tumor
necrosis factor (TNF) and interleukin-1 (IL-1), and also microbial
products (lipopolysaccharide (LPS), i.e.) activate IKKβ, mediating the
classical attributes of inﬂammation [13].
Regarding PLGA-based nanoparticles, they are extensively taken
up by non-phagocytic eukaryotic cells, macrophages and dendritic
cells [14]. However, such clear uptake studies with large-sized
polymer particles have not been shown conclusively. It is quite
possible that bigger-sized particles such as microparticles are
localized mainly in the cell membrane. This fact demands more time
to the particles be engulfed and can lead to a physical disturbance in
the membrane, involving or not the participation of speciﬁc receptors,
and provoking an inﬂammatory response by different mechanisms.
In this study we produced PLGA nano and microparticles without
any encapsulated bioactive to be examined with respect to their
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cytokine production.We analyzed by confocal images the interactions
of different sized polymer particles with these cells for correlating that
with NF-κB translocation to the cell nucleus after the uptake process
and the production of pro-inﬂammatory cytokines TNF-α and IL-1-β
by these cells.
2. Materials and methods
2.1. Materials
For the purposes of this study, Poly (D,L-lactide-co-glycolide)
(PLGA) with a co-monomer ratio of 50:50 (lactic/glycolic acid) and
molecular weight of 78 kDa was obtained from Boehringer Ingelheim
(Ingelheim, Germany). Poly (vinyl-alcohol) (Mowiols 40–88) was
obtained from Aldrich Chemicals (Wankee, WI, USA). Methylene
dichloride was purchased from Merck (Dietikon, Switzerland).
Lipopolysaccharide (LPS), the dye 6-coumarin and saponin were
from Sigma Chemical Co. (St. Louis, MO, USA). Acqua Poly/Mount was
obtained from Polysciences, Inc. (Warrington, PA). Lyso Tracker™ Red
was from Molecular Probes. The Limulus Amoebocyte Lysate test (LAL
test, QCL-1000, Bio Whittaker, CAMBREX Company, Walkersville, MD,
USA) was used for the detection of endotoxin in the particles. RPMI-
1640medium, fetal bovine serum (FBS) and antibiotics (penicillin and
gentamicin) were from Gibco (Grand Island, NY, USA). For cell
cultures were used non-tissue culture treated plates from Becton
Dickinson (BD Falcon, Franklin Lakes, NJ, USA).
2.2. Micro and nanoparticles preparation
Microparticles were prepared using an oil-in-water (O/W)
emulsion solvent extraction–evaporation process as previously
described [15,16]. In brief, 10 ml of methylene dichloride containing
30 mg of PLGA were homogenized. This phase was poured into an
external aqueous phase (40 ml of polyvinyl alcohol (Sigma Chemical
Co.) solution at 3% w/v) and stirred mechanically (RW20; IKA
Labortechnik, Germany) at 600 rpm for 4 h to extract the organic
solvent. For nanoparticles preparation, the O/W emulsion solution
was homogenized at 24,000 rpm for 5 min by using a T25 Ultraturrax
homogenizer (IKA, Labortechnik, Germany). The solution was then
placed under a magnetic stirring condition for 4 h to evaporate the
solvent. Finally, both micro/nanoparticles formed were washed three
times with doubly distilled water, centrifuged and then freeze-dried.
Fluorescent-labeled particles were prepared by adding 6-coumarin
(green ﬂuorescence; Sigma Aldrich) to the organic phase. The amount
of 6-coumarin/mg polymer was 0.15 μg [17].
2.3. Micro and nanoparticle characterization
Particle diameterswere characterized using a particle size analyzer
(LS 13 320 Laser Diffraction Particle Size Analyzer; Beckman Coulter,
USA). Zeta potential analysis of the particles was performed using a
Nano Zeta Sizer (Malvern instruments, England). To determine
whether the particles and media were contaminated by LPS, a LAL
test was performed. The shape and surface of the dried micro and
nanoparticles were observed by scanning electron microscopy (SEM),
using a ZEISS scanning microscope (ZEISS, Evo 50, Cambridge,
England).
2.4. Uptake assay with ﬂuorescent particles
J774 murine “macrophage-like” cells (5×105/24-wells) were
obtained from European Collection of Animal Cell Cultures (Salisbury,
UK). Cells were plated on wells containing coverslips and co-incubated
with 1 mg/ml of ﬂuorescent particles during 2 and 4 h. After this
incubation period, the cells were washed twice with PBS, ﬁxed for15min with 2% paraformaldehyde in PBS and rinsed in PBS. Coverslips
were mounted using Acqua Poly/Mount (Polysciences) and examined
by confocal microscopy (Leica TCS SP5 AOBS — Leitz, Manheim,
Germany).
2.5. Confocal laser scanning microscopy (CLSM) analyses
J774 murine macrophages (5×105 cells/well) were grown on
coverslips inside sterile 24-well tissue culture plates and incubated
with ﬂuorescent nano or microparticles (1 mg/ml) at 37 °C, 5% CO2 for
4 h. In order to analyze intracellular localization of particles, cells were
later incubated with organelle-speciﬁc contrasting ﬂuorescent dye
Lyso Tracker™ Red (Molecular Probes) 160 nM, for 30 min at 37 °C
and washed three times with sterile 50 mM phosphate-buffered
saline (PBS). The endolysosomes appeared red in color when labeled
with Lyso Tracker™ Red and visualized under RITC ﬁlter. Series of z-
sections were performed using CLSM following which the colocaliza-
tion of the ﬂuorescent particles within the endolysosomal compart-
ments at different sections of the cells could be visualized under both
FITC and RITC ﬁlters. The extent of colocalization between ﬂuorescent
particles (green) and endolysosomal compartments (Lyso Tracker™
Red) was quantiﬁed using the Jacop plug-in for Image J [18]. The
background of the collected images was corrected by the Image J
algorithm plug-in. The speciﬁc algorithm used was based on the
Mander's overlap coefﬁcient [18]. This coefﬁcient varies from 0 to 1,
the former corresponding to non-overlapping images and the latter
reﬂecting 100% colocalization between both images.
For NF-κB translocation assay, cells were 4 h incubated in culture
medium, with LPS (0.5 μg/ml), used as positive control, and with
1 mg/ml of non-ﬂuorescent nano or microparticles. They were washed
twice with PBS and ﬁxed for 15 min with 2% paraformaldehyde in PBS
and rinsed in PBS with 0.1 M glycine for 5 min. Then, cells were
permeabilizedwith 0.01% of saponin in PBS for 20 min and blockedwith
3% donkey serum (Jackson ImmunoResearch Laboratories) in PBS for
40 min at room temperature. J774murinemacrophageswere incubated
1 h with rabbit polyclonal antibodies against NF-κB p65 subunit
(Santa Cruz Biotechnology). After PBS wash, secondary antibodies
(rabbit anti-IgG labeled with Alexa-Fluor 594 (Invitrogen Molecular
Probes))were added for 30 min. DAPI (Calbiochem)was used for nuclei
staining during 15 min. After the described staining steps, coverslips
were mounted using Acqua Poly/Mount (Polysciences) and examined
for intracellular localization of the particles and NF-κB translocation by
confocal microscopy (Leica TCS SP5 AOBS— Leitz, Manheim, Germany).
Densitometric analyses of the images were performed using Image J.
For each cell nucleus, thepixel density I.O.D. (integrated optical density)
was determined by selecting a circle of identical surface for all
determinations, designed to entirely cover the area of interest.
2.6. Pro-inﬂammatory cytokines production by particles-stimulated J774
macrophages
In order to evaluate the in vitro inﬂammatory cytokines produc-
tion, J774 macrophages (5×105cells/well) were incubated for 4 h
with micro or nanoparticles at 37 °C, 5% of CO2. At the end of the
experiment, cell-free supernatants were collected for IL-1β and TNF-α
detection assays. Cytokine levels were measured by ELISA, using
commercially available antibodies with reference standard curves.
The optical density of samples was determined at 450 nm in a
microplate reader. Sensitivities were N8.0 pg/ml.
2.7. Statistical analysis
The data are presented as mean±S.E.M. and analyzed using
unpaired t-test. Values of Pb0.05 were considered statistically
signiﬁcant.
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3.1. Size, zeta potential and surface morphology
Lyophilized particles were dispersed in distilled water and submit-
ted to analysis of size distribution. For microparticles, the average
diameterwas6.5±3.9 μmand for nanoparticles, 389 nmwith PdI=0.2.
The average zeta potential was −34.5 and −17.2±6.1 mV, for micro
and nanoparticles, respectively. Scanning electron micrographies of
micro and nanoparticles are shown in Fig. 1. Both particles were
sphericalwith smooth surface and irregularities were not observed. The
particles (2 batches) and also the media were assayed for detection of
endotoxin activity using the Limulus Amoebocyte assay (LAL test).
Endotoxin activity in all batches was lower than 0.1 EU/μg. According to
the European Pharmacopeia, the safety level for intravenous adminis-
tration is 5 EU/kg/h.
Our results show that both micro and nanoparticles had typical
negative zeta potential attributed to PLGA preparations due to carboxyl
groups present in their structure. Also, Fig. 1 shows that micro and
nanoparticles produced were intact for the use in the assays.
3.2. Analysis of particles' uptake
To visualize particles' uptake by J774 macrophages, cells were
incubated with both PLGA micro and nanoparticles for two different
time points (2 and 4 h). These times were chosen in order to get an
idea about the initial inﬂammatory behavior of phagocytic cells in the
presence of particles. Studies were conducted using ﬂuorescent
particles. Fluorescence microscopy showed that most of the nano-
particles (389 nm) were localized intracellularly and better uptakeFig. 1. (A) Micro and (B) nanoparticles morphologieswas observed for 4 h incubation (Fig. 2). The interesting observation
was that PLGAmicroparticles of size 6.5 μmwere found to be attached
to the cells surface at 2 and 4 h incubation. In this context, few
microparticles could be seen inside the cells when compared to
nanoparticles.
Based on our previous studies employing PLGA microparticles for
phagocytosis purposes [15,19], in this study, we decided to use the
same diameter range (5–7 μm) achieved to compare with nanopar-
ticles. The particles' diameters were adequate for cell phagocytosis,
since J774 murine “macrophage-like” cells efﬁciently engulfed them.
In vitro studies have shown that microparticles having less than 10 μm
are efﬁciently internalized by macrophages [20]. Regarding the
possible toxic effect of particles at concentration of 1 mg/ml employed
during 2–4 h in our experiments, is well know that PLGA has an inert
proﬁle, showing high biocompatibility [3]. Also, other studies
conducted with different polystyrene beads' size (20 and 200 nm)
at low and high concentrations demonstrated limited cytotoxicity
(assessed by MTT and LDH assays) over the 48 h period [21].
It has been documented that size and surface chemistry of particles
do inﬂuence particle uptake [22,23] and in particular, hydrophobic
polymer particles have the tendency to adhere to the cell surface [24].
Also, the nanoparticles used in this study presented less negative
charge on the surface of the polymer, as determined by zeta potential,
when compared to microparticles (−17.2 vs.−34.5 mV). Since cell
membrane has negative polarity, this fact could contribute to better
interaction with the nanoparticles, improving their uptake. From
these results, we decided to speculate whether micro or nanoparticles
per se, without any encapsulated bioactive could confer different
inﬂammatory proﬁles in J774 murine “macrophage-like” cells after
the uptake process.assessed by scanning electron microscopy (SEM).
Fig. 2. Uptake assay in J774 murine “macrophage-like” cells using different ﬂuorescent PLGA particles (micro and nanoparticles) at 2 and 4 h. Each bar represents 10 μm.
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J774 macrophages
The colocalization of particles and lysosomes showed up as yellow
ﬂuorescence in the overlay between green ﬂuorescent micro (Fig. 3A)
or nanoparticles (Fig. 3B) and red ﬂuorescent vesicles. No evident
colocalization of the ﬂuorescent microparticles was observed within
the labeled cells after 4 h incubationwhen compared to nanoparticles.
This fact suggests that theywere seen to be attached to the cell surface
or they demand more time to be engulfed by the cells. On the other
hand, the colocalization of nanoparticles and lysosomes (measured by
the overlap coefﬁcient) was statistically greater compared to
microparticles (Fig. 3C). A great number of nanoparticles could be
seen inside the vesicles, suggesting the prompt entrance of them to
cell cytoplasm, as described by other studies [10].
Regarding external stimuli and further inﬂammatory cytokines
production by many cells, previous studies have shown that
perturbations in the cell cycle can activate the NF-κB pathway [25].
In this context, statistically, our results from I.O.D. quantiﬁcations
(Fig. 4G) show that microparticles (Fig. 4E) are more potent
inﬂammatory stimulus than nanoparticles (Fig. 4F) and also LPS
(Fig. 4D) in activating NF-κB translocation to cell nucleus.
3.4. Microparticles-stimulated J774 macrophages produce more
inﬂammatory cytokines
It is a fact that macrophages can produce inﬂammatory cytokines
duringphagocytosis process and cell activation [26]. In order to getmore
conclusive data about the acute inﬂammation response (2–4 h) elicited
by J774 macrophages after particles' uptake, cytokines production was
determined by ELISA. Microparticles induced signiﬁcant release ofTNF-α compared with medium and especially with nanoparticles
(Fig. 5A). The same proﬁle was observed for IL-1β production by the
cells (Fig. 5B). Correlating these quantitative results with those
obtained from NF-κB translocation assay, we can suggest that
PLGA microparticles are more inﬂammatory than nanoparticles
when J774 murine macrophages were used as test cells. Many
studies have shown a large number of encapsulated substances
and their role in modulating the immune response. However, few
data are known about the difference between micro and
nanoparticles per se, without encapsulated active compound, in
acting directly on a nuclear transcription factor, such as NF-κB, and
the consequences for cytokines production after the particles'
uptake possibly affecting the cellular phenotype (e.g. expression of
surface receptors, adhesion and costimulatory molecules).
In order to conﬁrm the need of the preformed NF-κB in the cell
cytoplasm to be further requested to nucleus compartment under the
presence of a stimulus (LPS,micro or nanoparticles), we conducted a set
of experiments employing the NF-κB inhibitor 6-amino-4-(4-
phenoxyphenylethylamino) quinazoline. This drug completely abol-
ished TNF-α production by the cells during 1 h pre-incubation. The
results showed thatmicro or nanoparticles were not able to restore any
level of this cytokine production (2–4 h) when NF-κB pathway was
inhibited. Interestingly, when IL-1β production was assessed at same
conditions, the results showed that bothmicro (60.8±20.2 pg/ml) and
nanoparticles (42.6±2.47 pg/ml) could restore this cytokine levels
under the effect of the NF-κB inhibitor. However, the values were not
statistically signiﬁcant between them. We can speculate that the
cytokines TNF-α and IL-1β present different times of induction when
cells were stimulated with the particles and also, pre-formed NF-κB
is needed to confer the distinct inﬂammatory responses elicited by
micro or nanoparticles. Other authors also demonstrate that PLG
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Fig. 3. Localization of ﬂuorescent (A) micro and (B) nanoparticles in J774 murine macrophages. Representative cells after treatment with dyes were selected at random and
series of optical sections (z-sections) were taken in the dual ﬁlter mode. Images captured in FITC (6-coumarin), RITC (Lysotracker) and dual mode were overlaid to
determine localization and colocalization of the particles inside the lysosomes (Merge). Each bar represents 10 μm. (C) Quantiﬁcation of ﬂuorescent particles/
endolysosomal compartments colocalization was determined as described in the Materials and methods. Measurements of overlap coefﬁcient show data from three
separated experiments (mean±S.E.M). **Pb0.01.
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oligomerization domain-like receptor (NLR), speciﬁcally NALP3 inﬂam-
masome, in dendritic cells [27]. Taking those results together with our
ﬁndings, another point to be discussed is the increase of adhesion
(CD11b) and/or costimulatory (CD86) molecules expression in phago-
cytic cells after PLG microparticles' uptake. In this context, we can infer
that although microparticles demand more time to be engulfed by the
macrophages they further activate intracellular inﬂammatory events in
a more potent proﬁle compared to nanoparticles. Also, their previous
and intense interaction with the membrane rufﬂes present on the
macrophages surface can increase the expression of the molecules
described above leading to NF-κB translocation to cell nucleus and
further pro-inﬂammatory cytokines production, as assessed.
This work suggests that although other studies had demonstrated
signiﬁcant differences in the modulation of immune responses by
employing micro or nano-structured biodegradable polymers, especially
for immunization purposes, is extremely important to evaluate thesepreparations without the encapsulated bioactive compound. Taken
together, our results show that PLGA microparticles (5–7 μm) are not
able to be phagocytosed by J774 macrophages with the same avidity
demonstrated for nanoparticles (389 nm) but instead, they attach to cell
membrane and constitute more potent inﬂammatory stimulus after
the uptake process. This fact leads to NF-κB translocation to cell
nucleus and further pro-inﬂammatory cytokines production by
microparticles-stimulated cells.Acknowledgments
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Fig. 4. NF-κB translocation assay in murine macrophage cell line J774 after micro or nanoparticles' uptake. Representative cells after 4 h incubation were selected at random and
series of optical sections (z-sections) were taken in the dual ﬁlter mode. Images were captured separated for DAPI (A), NF-κB (B, showed by white arrows) and dual mode (Merge).
(C) represents cells incubated only in culture medium (negative control); (D) cells stimulated with LPS (positive control); (E) and (F) cells incubated with 1 mg/ml of micro and
nanoparticles, respectively. (G) Densitometric measurements show data from three separated experiments (mean±S.E.M). *Pb0.05 and ***Pb0.001, values compared to medium;
#Pb0.05, microparticles compared to LPS; &&Pb0.01, microparticles compared to nanoparticles.
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Fig. 5. (A) TNF-α and (B) IL-1β production by J774 macrophages after 4 h incubation in
culture medium and with 1 mg/ml of micro or nanoparticles. The concentrations in the
supernatants were quantiﬁed by ELISA. Results are expressed as mean±S.E.M. (n=4);
**Pb0.01, values compared to medium. ##Pb0.01 and ###Pb0.001, microparticles
compared to nanoparticles.
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